Supports Danish clinical and translational research projects, especially those investigating the links between infectious and cardiometabolic diseases.
Funder: Novo Nordisk Foundation
Due Dates: August 19, 2026 | August 28, 2025 | September 15, 2021
Funding Amounts: Up to DKK 4,400,000 per grant (1–3 years); total call budget ~DKK 76 million; DKK 11 million reserved for infectious/cardiometabolic theme.
Summary: Supports Danish clinical or translational research projects involving patients or clinical methods, with special emphasis on the interplay between infectious and cardiometabolic diseases.
Key Information: PI must be an independent researcher at a Danish university/hospital/non-profit; salary for main applicant not covered.
This grant program aims to advance Danish clinical and translational research at a high international level. Supported projects must involve patients, clinical practice, diagnostic or therapeutic methods, or established animal models. A strategic focus is placed on research that explores the interactions between infectious diseases and cardiometabolic diseases, with a dedicated portion of the budget reserved for such projects. The program is designed for experienced, independent researchers leading innovative projects with clear relevance to human health and clinical practice.